dc.creatorMadrid S,Ana María
dc.creatorDíaz S,Mario
dc.creatorHurtado H,Carmen
dc.creatorAguilera O,Ledda
dc.creatorMena U,Boris
dc.date2011-05-01
dc.date.accessioned2017-03-07T16:38:55Z
dc.date.available2017-03-07T16:38:55Z
dc.identifierhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011000500004
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/405181
dc.descriptionBackground: Celiac disease (CD) is predominant in women and young people. Atypical, non-enteric symptoms are more common among adults. There is also an association between CD and neurological disorders, especially with cerebellar ataxia, polyneuropathy and epilepsy. Aim: To study the frequency of CD in a group of adults with cryptogenic epilepsy. Material and Methods: Twenty one patients with cryptogenic epilepsy, aged 20 to 65years (14 women) were studied, measuring IgA-anti transglutaminase antibodies and deamidated gliadin peptide (DGP) IgG and IgA antibodies. Results: One patient had elevated titers of both types of antibodies. Small bowel biopsy showed villous atrophy and lymphocytic infiltration compatible with CD. Conclusions: One of 21 adult patients with cryptogenic epilepsy had a silent CD.
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.sourceRevista médica de Chile v.139 n.5 2011
dc.subjectCeliac disease
dc.subjectEpilepsy
dc.subjectGliadin
dc.subjectPlasma transglutaminase
dc.titleEnfermedad celíaca silente en epilepsia criptogénica del adulto
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución